Recruiting OBSERVATIONAL NCT07353840
T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-CR (T-START-CR)
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Conditions
Peripheral T Cell Lymphoma
Updated 1 time since 2026 Last updated: Jan 12, 2026 Started: Jan 20, 2026 Primary completion: May 30, 2029 Completion: Sep 30, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates Peripheral T Cell Lymphoma and is currently actively recruiting participants. Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine leads this study, which shows 1 recorded version since 2026 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Data source: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .